Market Intelligence
Get comprehensive and up-to-date information about the Healthcare market and the export potential for your products and services!
For more information about our market research services, please contact our specialists for the relevant industry sectors.
Cancer Report to Help Shape Cancer Treatment and Management Strategies.
Hong Kong can be a launchpad for U.S. medical device companies to expand into the Greater Bay Area.
Saudi Arabia has introduced sweeping reforms and is investing heavily to implement a transformation of its healthcare sector.
Slovakia’s focus on healthcare readiness is opening new avenues for U.S. businesses in healthcare IT, telemedicine, cybersecurity, medical equipment, and more.
The Israeli Government and healthcare system are investing in innovative digital health solutions, creating opportunities for American companies in the sector.
United Kingdom: An update on plans to reform current medical device regulations.
Medical device registration is temporarily eased, creates a short window of opportunity for U.S. brands already sold in Algeria to increase their market share.
There is opportunity related to Malaysia’s genome sequencing, leading to precision medicine.
In recent years, Taiwan has made significant investments in biotech R&D, resulting in expanding opportunities for U.S. exporters in Taiwan biotech industry.
Kenya Hospital Association expansion and digital transformation creates opportunities for U.S. companies.
In Panama, the registration process for medical devices is overseen by the Ministry of Health (Ministerio de Salud or MINSA).
Japan’s super-ageing society will create business opportunities for American innovative medtech products used in home medical care.
Finding niche applications for Digital Adherence Technology is likely to be more successful.
With one of the world’s most comprehensive health data registries, Denmark is betting big on precision medicine with support from the public and private sectors
The Philippines’ new FDA regulation allows for a facilitated registration process for new drugs.